Increased excretion of a lipid peroxidation biomarker in autism.

It is thought that autism could result from an interaction between genetic and environmental factors with oxidative stress as a potential mechanism linking the two. One genetic factor may be altered oxidative-reductive capacity. This study tested the hypothesis that children with autism have increased oxidative stress. We evaluated children with autism for the presence of two oxidative stress biomarkers. Urinary excretion of 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-isoprostane-F2alpha (8-iso-PGF2alpha) were determined in 33 children with autism and 29 healthy controls. 8-iso-PGF2alpha levels were significantly higher in children with autism. The isoprostane levels in autistic subjects were variable with a bimodal distribution. The majority of autistic subjects showed a moderate increase in isoprostane levels while a smaller group of autistic children showed dramatic increases in their isoprostane levels. There was a trend of an increase in 8-OHdG levels in children with autism but it did not reach statistical significance. There was no significant correlation between the levels of the biomarkers and vitamin intake, dietary supplements, medicine, medical disorders, or history of regression. These results suggest that the lipid peroxidation biomarker is increased in this cohort of autistic children, especially in the subgroup of autistic children.

[1]  H. Herken,et al.  Pathophysiological role of nitric oxide and adrenomedullin in autism , 2003, Cell biochemistry and function.

[2]  D. Reif,et al.  Ferritin as a source of iron for oxidative damage. , 1992, Free radical biology & medicine.

[3]  Nancy J. Minshew,et al.  A preliminary 31P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes , 1993, Biological Psychiatry.

[4]  N. Vermeulen,et al.  Biomarkers of free radical damage applications in experimental animals and in humans. , 1999, Free radical biology & medicine.

[5]  B. Ames,et al.  8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. , 1999, Methods in enzymology.

[6]  I. Antolín,et al.  Melatonin increases gene expression for antioxidant enzymes in rat brain cortex , 1998, Journal of pineal research.

[7]  M. Seven,et al.  Changes in the Antioxidant System in Epileptic Children Receiving Antiepileptic Drugs: Two-Year Prospective Studies , 2001, Journal of child neurology.

[8]  M. Harrington.  The Other America , 1962 .

[9]  D. Cantor,et al.  Autism: Xenobiotic Influences , 1998, Toxicology and industrial health.

[10]  Barry Halliwell,et al.  Antioxidants in Nutrition, Health, and Disease , 1995 .

[11]  G. Moore,et al.  Evidence of altered energy metabolism in autistic children , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  E Courchesne,et al.  Autism Associated With the Mitochondrial DNA G8363A Transfer RNALys Mutation , 2000, Journal of child neurology.

[13]  S. Zoroglu,et al.  Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[14]  J. Blass,et al.  Autism and lactic acidosis , 1985, Journal of autism and developmental disorders.

[15]  T. Glauser,et al.  Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy. , 1998, Neuropediatrics.

[16]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .

[17]  S. Loft,et al.  Experimental study of oxidative DNA damage. , 1998, Free radical research.

[18]  D. Bandyopadhyay,et al.  Involvement of reactive oxygen species in gastric ulceration: protection by melatonin. , 2002, Indian journal of experimental biology.

[19]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[20]  J. Morrow,et al.  The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. , 1999, Drug metabolism reviews.

[21]  O. Olson,et al.  Distribution of serum selenium, copper, and zinc in normal human pregnancy. , 1985, Archives of environmental health.

[22]  The isoprostanes: Unique bioactive products of lipid peroxidation , 1997 .

[23]  L. Packer.  Oxygen radicals in biological systems. , 1984, Methods in enzymology.

[24]  I. Rapin,et al.  Clinical characteristics of language regression in children. , 2003, Developmental medicine and child neurology.

[25]  R. Reiter,et al.  Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin , 2002, Mechanisms of Ageing and Development.

[26]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[27]  M. Chez,et al.  Double-Blind, Placebo-Controlled Study of L-Carnosine Supplementation in Children With Autistic Spectrum Disorders , 2002, Journal of child neurology.

[28]  N. Zisapel,et al.  Prospects of the Clinical Utilization of Melatonin , 1998, Neurosignals.

[29]  D. Cantor,et al.  The neurotoxic etiology of the autistic spectrum disorders: a replication study , 2000 .

[30]  H. Savaş,et al.  Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[31]  J. Spollen,et al.  A preliminary trial of ascorbic acid as supplemental therapy for autism , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  Jenifer Juranek,et al.  Mitochondrial dysfunction in autistic patients with 15q inverted duplication , 2003, Annals of neurology.

[33]  Y. Karakoç,et al.  Lipid Peroxidation and Antioxidative Enzyme Activities in Childhood Epilepsy , 2002, Journal of child neurology.

[34]  S. Jovanovic,et al.  Antioxidants in Nutrition , 2000, Annals of the New York Academy of Sciences.

[35]  M. Sugama,et al.  [Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders]. , 1999, No to hattatsu = Brain and development.

[36]  W. Brown,et al.  Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.

[37]  A. Couteur,et al.  Autism diagnostic interview: A standardized investigator-based instrument , 1989, Journal of autism and developmental disorders.

[38]  S. Devaraj,et al.  Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. , 2001, Clinical chemistry.

[39]  T P Stein,et al.  Diet and nitrogen metabolism during spaceflight on the shuttle. , 1996, Journal of applied physiology.

[40]  L. Borjas,et al.  [Clinical heterogeneity of the autistic syndrome: a study of 60 families]. , 1992, Investigacion clinica.

[41]  Thomas K. H. Chang,et al.  The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats. , 2003, Free radical biology & medicine.

[42]  J. Morrow,et al.  ISOPROSTANES—RROSTAGLANDIN-LIKE COMPOUNDS FORMED IN VIVO INDEPENDENTLY OF CYCLOOXYGENASE , 1996 .

[43]  J. Morrow,et al.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. , 1999, Methods in enzymology.